3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasm Metastasis
2
Endometrial Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Myelodysplastic Syndromes
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
High Grade Serous Carcinoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Advanced Solid Tumours
1
Adenocarcinoma
1
Interventions
Specimen Handling
3
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
olaparib
1
durvalumab
1
defactinib
1
cediranib
1
capivasertib
1
Restraint, Physical
1
RO5126766
1
Immunoglobulin G
1
Hysterectomy
1
Fluid Therapy
1
Disulfides
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Endometrioid
×
ceralasertib
×
90 days
×
Clear all
No trials found.